Success Metrics

Clinical Success Rate
91.6%

Based on 76 completed trials

Completion Rate
92%(76/83)
Active Trials
10(9%)
Results Posted
18%(14 trials)
Terminated
7(7%)

Phase Distribution

Ph phase_4
13
12%
Ph phase_2
16
15%
Ph early_phase_1
4
4%
Ph not_applicable
61
57%
Ph phase_1
8
7%
Ph phase_3
4
4%

Phase Distribution

12

Early Stage

16

Mid Stage

17

Late Stage

Phase Distribution106 total trials
Early Phase 1First-in-human
4(3.8%)
Phase 1Safety & dosage
8(7.5%)
Phase 2Efficacy & side effects
16(15.1%)
Phase 3Large-scale testing
4(3.8%)
Phase 4Post-market surveillance
13(12.3%)
N/ANon-phased studies
61(57.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

89.4%

76 of 85 finished

Non-Completion Rate

10.6%

9 ended early

Currently Active

10

trials recruiting

Total Trials

107

all time

Status Distribution
Active(11)
Completed(76)
Terminated(9)
Other(11)

Detailed Status

Completed76
unknown10
Terminated7
Recruiting7
Active, not recruiting3
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
107
Active
10
Success Rate
91.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (3.8%)
Phase 18 (7.5%)
Phase 216 (15.1%)
Phase 34 (3.8%)
Phase 413 (12.3%)
N/A61 (57.5%)

Trials by Status

active_not_recruiting33%
withdrawn22%
terminated77%
recruiting77%
completed7671%
not_yet_recruiting11%
suspended11%
unknown109%

Recent Activity

Clinical Trials (107)

Showing 20 of 107 trialsScroll for more
NCT00230113Not Applicable

Effect of Omega-3 PUFA Supplementation in NAFLD Patients

Completed
NCT06279793Phase 2

Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients

Recruiting
NCT05613803Phase 3

Poly-unsaturated Fats for Improving Nasal Polyps and Asthma

Completed
NCT05822141Not Applicable

Omega-3 Fatty Acids as Regulators of Brown Adipose Tissue During Cold Exposure

Recruiting
NCT05404230Not Applicable

Prevention of Oxaliplatin-induced Nerve Damage in the Body's Extremities

Recruiting
NCT07575438Phase 2

Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk Adults

Not Yet Recruiting
NCT00536185Not Applicable

Heart & Health Study

Completed
NCT00682318Not Applicable

Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers

Active Not Recruiting
NCT07331103Not Applicable

RESOLving INflammation Through Diet for Health (RESOLVIN)

Recruiting
NCT06424860Phase 1

Fish Oil, Metformin and Heart Health in PCOS

Recruiting
NCT01351805Not Applicable

Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain

Completed
NCT06629103Phase 4

A Study in Healthy Subjects to Compare the Bioavailability of EPA + DHA

Active Not Recruiting
NCT01624792Not Applicable

Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2

Completed
NCT01442480Not Applicable

Cardioprotective Effects of Omega-3 Fatty Acids Supplementation in Healthy Older Subjects Exposed to Air Pollution Particles

Completed
NCT02629497Early Phase 1

Role of 12-lipoxygenase in Platelet Reactivity and Type 2 Diabetes Mellitus

Completed
NCT06981364Not Applicable

Minimum Time Effect of Fish Oil on Arterial Stiffness

Completed
NCT04460287Not Applicable

Bioavailability of Different Formulas Enriched With DHA Using Wet Mixing or Dry Blending Method

Completed
NCT05869526Not Applicable

A Comparison of the Effects of Krill Oil and Fish Oil Supplementation on Muscle Function in Older Adults

Completed
NCT06877494Phase 2

the Effects of Fish Oil Supplements on Choroidal Thickness and Blood Flow Perfusion in Children and Adolescents

Completed
NCT04116203Phase 1

Dietary Fish Oil Intervention in Polycystic Ovary Syndrome (PCOS)

Completed

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
107